Ampio Pharmaceuticals Inc (AMPE.A) Quote| Reuters.com
Edition:
United States

Ampio Pharmaceuticals Inc (AMPE.A)

AMPE.A on American Stock Exchange

1.29USD
1 Jul 2016
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.29
Open
$1.35
Day's High
$1.45
Day's Low
$1.21
Volume
248,426
Avg. Vol
86,270
52-wk High
$4.32
52-wk Low
$0.84

AMPE.A

Chart for AMPE.A

About

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for... (more)
No analyst recommendations are available for AMPE.A.

Overall

Beta: 0.28
Market Cap(Mil.): $67.10
Shares Outstanding(Mil.): 52.02
Dividend: --
Yield (%): --

Financials

  AMPE.A Industry Sector
P/E (TTM): -- 42.29 36.15
EPS (TTM): -0.61 -- --
ROI: -82.29 -6.23 14.31
ROE: -80.54 -5.61 15.51

BRIEF-Ampio launches clinical trial of ampion

* Ampio launches clinical trial of ampion for the treatment of osteoarthritis of the hand Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

May 10 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.